[Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].
作者信息
Iriondo A, Richard C, Hermosa V, Conde E, Garijo J, Cuadrado M A, Bello C, Muruzábal M J, Pérez-Encinas M, Zubizarreta A
出版信息
Med Clin (Barc). 1988 Oct 22;91(13):488-92.
PMID:3067007
Abstract
摘要
相似文献
1
2
[Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].
Schweiz Med Wochenschr. 1985 Oct 26;115(43):1521-2.
3
T-cell depletion with the monoclonal antibody Campath 1 to prevent graft-versus-host disease in ten high-risk adult patients.使用单克隆抗体Campath 1清除T细胞，以预防10例高危成年患者的移植物抗宿主病。
Haematologica. 1986 Jul-Aug;71(4):307-11.
4
[Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
Schweiz Med Wochenschr. 1985 Oct 26;115(43):1517-8.
5
The use of monoclonal antibodies in graft versus host disease prevention.
Haematologia (Budap). 1986;19(3):167-76.
6
[Application of monoclonal antibodies to bone marrow transplantation].
Gan To Kagaku Ryoho. 1988 May;15(5):1693-701.
7
8
XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.XomaZyme-CD5免疫毒素联合部分T细胞清除用于预防匹配无关供者骨髓移植后的移植物排斥反应和移植物抗宿主病。
Bone Marrow Transplant. 1994 May;13(5):571-5.
9
Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.慢性粒细胞白血病患者的骨髓移植：使用Campath-1进行T细胞清除可降低移植物抗宿主病的发生率，但可能会增加白血病复发的风险。
Bone Marrow Transplant. 1986 May;1(1):53-66.
Zotero 插件